Biomarker Dr. Nicole Schneiderhan-Marra Head of Pharma & Biotech +49 7121 51530-815 E-Mail CV Indicators for diagnosis and therapy Quantitative detection of a variety of biomarkers with simultaneous h
Collagen-based biomaterials and biochemical functionalization of collagen Dr. Xin Xiong Group Leader Biofunctionalized Surfaces +49 7121 51530-413 E-Mail CV Our innovative biomaterials research and ad
Biomarkers and Immunoassays Dr. Jens Göpfert Group Leader Applied Biomarkers and Immunoassays +49 7121 51530-471 E-Mail CV Analysis of biological changes with precise, reliable and highly sensitive an
Dr. Peter D. Jones Group Leader Biomedical Micro and Nano Engineering +49 7121 51530-800 E-Mail anzeigen Lab-on-chip (LoC) systems have been developed and applied in academic research for more than a
Production of Solid State Nanopores Dr. Peter D. Jones Group Leader Biomedical Micro and Nano Engineering +49 7121 51530-800 E-Mail anzeigen The research field of solid-state nanopores and nanofluidic
Biomarker and Assay Development Dr. Nicole Schneiderhan-Marra Head of Pharma & Biotech +49 7121 51530-815 E-Mail anzeigen Dr. Markus Templin Group Leader Assay Development +49 7121 51530-828 E-Mail an
Microtumor Models Dr. Christian Schmees Group Leader Tumor Biology +49 7121 51530-881 E-Mail anzeigen Patient-derived microtumors for drug development and compound efficacy testing By developing novel
DigiWest® - High Content Protein Profiling Dr. Markus Templin Group Leader Assay Development +49 7121 51530-828 E-Mail anzeigen DigiWest® is an advanced immunoassay technology based on the Western blo
Online Deglycosylation Dr. Anne Zeck Group Leader Bioanalytics +49 7121 51530-811 E-Mail anzeigen Use of a new enzyme for online deglycosylation in HDX-MS workflow Protein-protein interaction sites or
Organ-on-Chip Prof. Dr. Peter Loskill Group Leader Organ-on-Chip +49 7121 51530-699 E-Mail anzeigen In the Organ-on-Chip group, we are engaged in the development and qualification of Organ-on-Chip (Oo
